Free Trial

TriMas Corporation (NASDAQ:TRS) Shares Acquired by Pzena Investment Management LLC

TriMas logo with Industrials background

Pzena Investment Management LLC lifted its position in shares of TriMas Corporation (NASDAQ:TRS - Free Report) by 0.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,135,554 shares of the industrial products company's stock after purchasing an additional 14,942 shares during the period. Pzena Investment Management LLC owned about 5.24% of TriMas worth $50,036,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Deutsche Bank AG increased its stake in shares of TriMas by 45.6% in the fourth quarter. Deutsche Bank AG now owns 36,305 shares of the industrial products company's stock worth $893,000 after buying an additional 11,363 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of TriMas by 3.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 605,502 shares of the industrial products company's stock worth $14,889,000 after buying an additional 22,656 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of TriMas by 3,802.9% in the first quarter. GAMMA Investing LLC now owns 14,948 shares of the industrial products company's stock worth $350,000 after buying an additional 14,565 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of TriMas by 3.7% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,106 shares of the industrial products company's stock worth $568,000 after buying an additional 834 shares during the last quarter. Finally, Quantbot Technologies LP increased its stake in shares of TriMas by 203.5% in the fourth quarter. Quantbot Technologies LP now owns 11,978 shares of the industrial products company's stock worth $295,000 after buying an additional 8,031 shares during the last quarter. 99.42% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at TriMas

In other news, Director Shawn Sedaghat purchased 410,172 shares of TriMas stock in a transaction dated Wednesday, May 21st. The stock was bought at an average price of $25.43 per share, with a total value of $10,430,673.96. Following the completion of the acquisition, the director owned 1,810,821 shares in the company, valued at $46,049,178.03. The trade was a 29.28% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Adrianne Shapira purchased 4,000 shares of TriMas stock in a transaction dated Thursday, June 5th. The shares were purchased at an average cost of $25.82 per share, with a total value of $103,280.00. Following the acquisition, the director owned 8,476 shares of the company's stock, valued at approximately $218,850.32. This trade represents a 89.37% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have bought 971,649 shares of company stock valued at $24,585,343. Corporate insiders own 14.20% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. BWS Financial restated a "buy" rating and issued a $40.00 price target on shares of TriMas in a research note on Wednesday, April 30th.

Read Our Latest Stock Report on TriMas

TriMas Stock Performance

TRS stock traded up $0.62 during trading on Thursday, hitting $30.04. 549,800 shares of the company's stock traded hands, compared to its average volume of 363,364. The company has a quick ratio of 1.49, a current ratio of 2.82 and a debt-to-equity ratio of 0.63. TriMas Corporation has a 52 week low of $19.33 and a 52 week high of $30.43. The stock has a fifty day moving average price of $27.16 and a two-hundred day moving average price of $24.54. The stock has a market capitalization of $1.22 billion, a price-to-earnings ratio of 39.01 and a beta of 0.63.

TriMas (NASDAQ:TRS - Get Free Report) last released its earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.03. TriMas had a net margin of 3.36% and a return on equity of 10.54%. The firm had revenue of $241.67 million during the quarter, compared to analyst estimates of $235.41 million. During the same quarter in the previous year, the firm earned $0.37 earnings per share. The firm's revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, equities analysts anticipate that TriMas Corporation will post 1.69 EPS for the current fiscal year.

TriMas Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th were paid a dividend of $0.04 per share. The ex-dividend date of this dividend was Tuesday, May 6th. This represents a $0.16 annualized dividend and a yield of 0.53%. TriMas's payout ratio is 20.78%.

About TriMas

(Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Recommended Stories

Institutional Ownership by Quarter for TriMas (NASDAQ:TRS)

Should You Invest $1,000 in TriMas Right Now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines